| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/20/2007 | EP1797189A2 Encapsidation system for production of recombinant virus-like particles |
| 06/20/2007 | EP1797175A1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
| 06/20/2007 | EP1797174A1 Method for preparing viral material |
| 06/20/2007 | EP1796719A1 Refrigerator-temperature stable influenza vaccine compositions |
| 06/20/2007 | EP1159405B1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 06/20/2007 | EP1056838B1 Method for the development of an hiv vaccine |
| 06/20/2007 | EP0745121B1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
| 06/20/2007 | CN1984992A HBV particles containing HBV-RNA |
| 06/20/2007 | CN1322137C Equine infections anaemia virus (EIAV) based |
| 06/20/2007 | CN1322120C Bivalent hepatitis B-encephalitis B vaccine |
| 06/20/2007 | CN1322119C Mandarin fish rhabdo virus toxic strain, its preparation method and application |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/19/2007 | US7232685 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 06/19/2007 | US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus |
| 06/19/2007 | US7232564 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 06/19/2007 | CA2482021C Removal of adenine during a process of pathogen reducing blood and blood components |
| 06/19/2007 | CA2287478C Methods for increasing the efficiency of recombinant aav product |
| 06/14/2007 | WO2007067808A2 Immunogenic composition based on conditionally live virion and method for producing the same |
| 06/14/2007 | WO2006135413A3 Encapsidation system for production of recombinant virus-like particles |
| 06/14/2007 | WO2003012126A3 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 06/14/2007 | US20070134791 Cells for detection of enteroviruses |
| 06/14/2007 | US20070134271 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 06/14/2007 | US20070134270 Chicken rna polymerase i promoter and the use thereof |
| 06/14/2007 | US20070134207 Isolated phages and their use in food or pet food products |
| 06/14/2007 | US20070134201 Archaeon expression system |
| 06/14/2007 | CA2639074A1 Marked bovine viral diarrhea virus vaccines |
| 06/14/2007 | CA2632456A1 An hiv-1 latency model for high throughput screening |
| 06/13/2007 | EP1795601A1 Cell for producing retrovirus vector |
| 06/13/2007 | EP1795590A1 Mixed cell diagnostic systems |
| 06/13/2007 | EP1794329A2 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | CN1981040A Recombinant virus vector for gene introduction in lymphocyte |
| 06/13/2007 | CN1981033A Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 06/13/2007 | CN1981032A A novel strain of sars-associated coronavirus and use thereof |
| 06/13/2007 | CN1977970A Method for purifying viral vaccine by mixed bed gel filtration chromatography |
| 06/12/2007 | US7229823 Methods for increasing the efficiency of recombinant AAV product |
| 06/12/2007 | US7229761 Method of constructing a synthetic polynucleotide |
| 06/12/2007 | US7229625 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 06/12/2007 | US7229624 Ordered molecular presentation of antigens, method of preparation and use |
| 06/12/2007 | CA2215834C Dna encoding human papillomavirus type 18 |
| 06/12/2007 | CA2173975C Recombinant adenoviral vector and methods of use |
| 06/12/2007 | CA2130828C Non-azo naphthalimide dyes and uses for same |
| 06/12/2007 | CA2113712C Papilloma virus vaccine |
| 06/12/2007 | CA2076839C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 06/07/2007 | WO2007064462A1 Phage particle diagnostic reagents |
| 06/07/2007 | WO2007062543A1 The thermophilic long-chain alkane monooxygenase and its encoding gene, and their uses |
| 06/07/2007 | WO2007011711A3 Paramyxoviridae virus preparations |
| 06/07/2007 | US20070130634 Geranylgeranyl pyrophosphate synthases |
| 06/07/2007 | US20070128711 Recombinant construct of two West Nile viruses; e.g. strains NY99 and WN1415; use as vaccine |
| 06/07/2007 | US20070128700 Methods to culture circovirus |
| 06/07/2007 | US20070128693 Method for the inactivation and removal of dengue virus from biological samples |
| 06/07/2007 | US20070128692 Chimeric empty capsids of the infectious bursal disease viruse (ibdv), obtainment process and applications |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128630 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 06/07/2007 | US20070128224 nucleic acid molecules derived from its genome, the proteins and peptides encoded by the nucleic acid molecules, for use in medical diagnosis and/or as vaccines |
| 06/07/2007 | US20070128219 Molecular antigen arrays |
| 06/07/2007 | US20070128177 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 06/07/2007 | US20070128165 Recombinase-Based System for Expression of Foreign Proteins Using Adenovirus Vectors |
| 06/06/2007 | EP1792997A1 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 06/06/2007 | EP1791556A2 Modified hiv-1 envelope proteins |
| 06/06/2007 | EP1379660B1 Self-replicating rna molecule from hepatitis c virus |
| 06/06/2007 | EP0886679B1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/06/2007 | DE10051628B4 Einzelsträngiges Oligonukleotid und dessen Verwendung Single-stranded oligonucleotide and its use |
| 06/06/2007 | CN1977050A Determination of hepatitis c virus genotype |
| 06/05/2007 | US7227010 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 06/05/2007 | US7226912 Hepatitis C virus non-structural NS3/4A fusion gene |
| 06/05/2007 | US7226786 Envelope gene-deficient Paramyxovirus vector |
| 06/05/2007 | US7226784 Isolated nucleotides encoding arabidopsis senescence-induced elF-5A |
| 06/05/2007 | US7226775 Treating the solution with an ionic surfactant to dissociate the endotoxin from the amphiphilic solution; filtering the solution through a molecular weight cut-off filter to retain the amphiphilic drug or vaccine |
| 06/05/2007 | US7226774 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 06/05/2007 | US7226604 Chemically inactivated EHV-1 KyA virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer |
| 06/05/2007 | US7226603 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/05/2007 | US7226602 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 06/05/2007 | CA2143442C Dorsal tissue affecting factor and compositions |
| 06/02/2007 | CA2632245A1 Novel plant virus particles and methods of inactivation thereof |
| 05/31/2007 | WO2007061141A1 Mutant paramyxovirus and method for production thereof |
| 05/31/2007 | WO2007061092A1 Countermeasure against infection with floating virus |
| 05/31/2007 | WO2007060725A1 Recombinant polyvalent vaccine |
| 05/31/2007 | WO2007005934A3 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 05/31/2007 | CA2630770A1 Recombinant polyvalent vaccine |
| 05/30/2007 | EP1790658A2 Anti-viral vectors |
| 05/30/2007 | CN1973038A HCV RNA having novel sequence |
| 05/30/2007 | CN1972711A Therapeutic vaccine and method of use |
| 05/30/2007 | CN1972710A Methods and compositions comprising bacteriophage nanoparticles |
| 05/30/2007 | CN1970774A Porcine alpha-interferon recombinant adenovirus and its construction method and application |
| 05/30/2007 | CN1970764A Porcine beta-interferon recombinant adenovirus and its construction method and application |
| 05/30/2007 | CN1970763A Shortened anti-oncogene p53 capable of increasing sensitivity of human lung cancer cell to antineoplastics |
| 05/30/2007 | CN1970080A Method for producing virus vaccine by using suspended Vero cell |
| 05/30/2007 | CN1318596C Vectors based on recombinant defective viral gene group, and their use in formulation of vaccines |
| 05/30/2007 | CN1318581C Method for removing the activity of coronavirus by using supercritical fluid |
| 05/30/2007 | CN1318580C Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method |
| 05/30/2007 | CN1318449C Application of anti SARS specificity IgY in preparation dor preventing and treating SARS |
| 05/29/2007 | US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis |
| 05/29/2007 | US7223743 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/29/2007 | US7223595 Use of purified Streptomyces griseus trypsin for production of a biomass of cells and viral propagation |
| 05/29/2007 | US7223593 Anticancer agents; gene coding immunomoderator cytokine protein |
| 05/29/2007 | US7223585 Viral purification methods |
| 05/29/2007 | US7223584 Genome which overexpresses G protein to increase apoptosis in infected cells |
| 05/29/2007 | US7223560 DNA virus for use as transfection and protein expression tool in genetic engineering; bioreactors for screening protein folding activities; diagnosis and treatment of polypeptide misfolding disorders |
| 05/29/2007 | US7223411 Administering a mutated herpesvirus having a mutation in genes encoding a protein essential for viral genome replication to render the herpesvirus replication defective; effecting an antibody subclass shift of IgG2a/IgG upon in vivo administration |